LATIN AMERICAN PATENTS DISPUTE

5 June 1994

Venezuela, Colombia and Mexico, the Group of Three trading zone (Marketletter February 21), is divided over the issue of intellectual property, with the two Andean Pact countries, Colombia and Venezuela, against Mexican patent legislation proposals.

The two are maintaining the position of the Cartagena Agreement (Andean Pact Group) and opposing Mexico on the elimination of the exemption from patenting of the World Health Organization essential drugs list. They oppose Mexico's proposal to recognize a pipeline clause similar to that contained in its patent law, and also Mexico's view that parallel imports should only be domestic and not foreign.

The free trade agreement was signed in May and is expected to take effect January 1, 1995. The total free trade area incorporates 140 million consumers and is valued at around $115 billion.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight